The present invention provides a method to increase the concentration of shatavarin I and shatavarin IV in an extract derived from roots of A. racemosus. The method comprises the steps of adding roots of A. racemosus in a solvent, wherein the solvent is methanol: water mixture or ethanol: water mixture; stirring the roots in the solvent at 90 C.; filtering to separate the residue from the filterate; evaporating the residue to dry it to obtain dried extract comprising of shatavarin I and shatavarin IV at a concentration of 4-6.5%.

The present invention provides a method to increase the concentration of shatavarin I and shatavarin IV in an extract derived from roots of A. racemosus. The method comprises the steps of adding roots of A. racemosus in a solvent, wherein the solvent is methanol: water mixture or ethanol: water mixture; stirring the roots in the solvent at 90 C.; filtering to separate the residue from the filterate; evaporating the residue to dry it to obtain dried extract comprising of shatavarin I and shatavarin IV at a concentration of 4-6.5%.

The invention disclosed herein is a synergistic herbal composition comprising extracts of Mucuna pruriens, Cynara cardunculus, Trigonella foenum graecum, Withania somnifera and L-arginine along with pharmaceutically acceptable excipients, having libido enhancing, testosterone levels increasing and ejaculation delaying properties. The present invention also disclosed herein a process for preparation of said composition.

The invention disclosed herein is a synergistic herbal composition comprising extracts of Mucuna pruriens, Cynara cardunculus, Trigonella foenum graecum, Withania somnifera and L-arginine along with pharmaceutically acceptable excipients, having libido enhancing, testosterone levels increasing and ejaculation delaying properties. The present invention also disclosed herein a process for preparation of said composition.

Pain relief compositions are described for topical application to penetrate deep into the skin, muscles, and joints. The pain relief compositions are prepared as creams for topical applying to the skin. The pain relief compositions contain active ingredients such as DMSO, capsaicin, menthol, eucalyptus extract, chamomile oil, methyl salicylate, and cayenne oil. One or more of the active ingredients is included in the pain relief composition as nanoparticles. Methods for preparing and for using the pain relief compositions are also described.

Pain relief compositions are described for topical application to penetrate deep into the skin, muscles, and joints. The pain relief compositions are prepared as creams for topical applying to the skin. The pain relief compositions contain active ingredients such as DMSO, capsaicin, menthol, eucalyptus extract, chamomile oil, methyl salicylate, and cayenne oil. One or more of the active ingredients is included in the pain relief composition as nanoparticles. Methods for preparing and for using the pain relief compositions are also described.

A medical treatment composition to treat one or more medical conditions, methods for preparation and treatment method are provided. The liquid composition comprises equal parts Sansevieria and ground/blended Cloves. The composition is capable of use in treating and curing cancer. A preparation method may comprise preparing a liquid Sansevieria component, preparing a liquid Clove component, adding the Sansevieria component to the Clove component, and permitting a resulting Sansevieria and ground Clove mixture to sit at room temperature for 24 hours, to provide a liquid medical treatment composition comprising by volume 50% of a Sansevieria component and 50% of a Clove component. Methods of treating cancer may include administering the composition.

A medical treatment composition to treat one or more medical conditions, methods for preparation and treatment method are provided. The liquid composition comprises equal parts Sansevieria and ground/blended Cloves. The composition is capable of use in treating and curing cancer. A preparation method may comprise preparing a liquid Sansevieria component, preparing a liquid Clove component, adding the Sansevieria component to the Clove component, and permitting a resulting Sansevieria and ground Clove mixture to sit at room temperature for 24 hours, to provide a liquid medical treatment composition comprising by volume 50% of a Sansevieria component and 50% of a Clove component. Methods of treating cancer may include administering the composition.

The present invention relates to a 100% natural product consisting of natural matrices showing emerging properties, which allows to re-establish a correct bone metabolism by correcting the behavior of mesenchymal stem cells and re-establishing the correct balance between the cell populations that allow bone growth or remodeling. The product of the invention, as demonstrated by the inventors, is itself a natural matrix, representing native natural intelligence, said natural intelligence being the only capable to allow a physiological endogenous interconnection with other entities which are self-assembled in nature, such as the human species. By reconstituting the correct functioning of bone metabolism, the product achieves beneficial results on a systemic scale ameliorating systemic metabolism and inflammatory status. Factually, the invention allows for a shift of paradigm based on the passage from a deterministic validation of properties to a probabilistic one based on functional redundancy logics, that will grant an industrially viable source of innovation for manufacturers in the field of 100% natural therapeutic or beneficial products.

The present invention relates to a 100% natural product consisting of natural matrices showing emerging properties, which allows to re-establish a correct bone metabolism by correcting the behavior of mesenchymal stem cells and re-establishing the correct balance between the cell populations that allow bone growth or remodeling. The product of the invention, as demonstrated by the inventors, is itself a natural matrix, representing native natural intelligence, said natural intelligence being the only capable to allow a physiological endogenous interconnection with other entities which are self-assembled in nature, such as the human species. By reconstituting the correct functioning of bone metabolism, the product achieves beneficial results on a systemic scale ameliorating systemic metabolism and inflammatory status. Factually, the invention allows for a shift of paradigm based on the passage from a deterministic validation of properties to a probabilistic one based on functional redundancy logics, that will grant an industrially viable source of innovation for manufacturers in the field of 100% natural therapeutic or beneficial products.